MoneyWorks4Me

Sudarshan Pharma Industries to subscribe 100% stake in Ratna Lifesciences

03 Aug 2023 Evaluate

Sudarshan Pharma Industries has entered into an agreement for subscription of shares of Ratna Lifesciences equivalent to 100% of the shareholding of the Company as wholly owned subsidiary Company, as on date August 02, 2023, representing 100% holding in Ratna Lifesciences. The cost of acquisition will be Rs 550 lakh. 

Sudarshan Pharma Industries is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..